Section Arrow
Quote
BMY.NYSE
- Bristol-Myers Squibb Co
Quotes are at least 15-min delayed:2026/03/10 06:01 EDT
Pre Market
Last
 60.63
0 (0.00%)
Bid
59.11
Ask
60.75
High 60.63 
Low 60.43 
Volume 440 
Regular Hours (Closed)
Last
 60.63
+0.34 (+0.56%)
Day High 
60.64 
Prev. Close
60.29 
1-M High
62.8864 
Volume 
10.96M 
Bid
59.11
Ask
60.75
Day Low
59.25 
Open
59.55 
1-M Low
59.23 
Market Cap 
122.78B 
Currency 美元 
P/E 17.41 
%Yield 4.11 
10-SMA 61.45 
20-SMA 60.99 
50-SMA 57.54 
52-W High 63.33 
52-W Low 42.52 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.46/5.87
Enterprise Value
167.45B
Balance Sheet
Book Value Per Share
9.07
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
48.20B
Operating Revenue Per Share
22.07
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
Pre Market 0.568 +0.0581 +11.39%
PFEPfizer26.81-0.24-0.89%19.84PE
Pre Market 26.88 +0.07 +0.26%
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
Pre Market 39.53 -0.25 -0.63%
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
Pre Market 60.63 0 0.00%
MRKMerck & Co117.11+1.32+1.14%15.9PE
Pre Market 117.48 +0.37 +0.32%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.